Investigational Site Number : 2500002

Dijon 21079

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Malignant Melanoma, Squamous Cell Carcinoma of Skin

Studies at this site

• A Study of SAR444245 Combined With Cemiplimab for the Treatment of Participants With Various Advanced Skin Cancers (Pegathor Skin 201) — Stopped early
• Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation — Completed